ARTICLE | Company News
Novo Nordisk sales and marketing update
September 14, 2015 7:00 AM UTC
Germany’s Institute for Quality and Efficiency in Health Care (IQWiG) said in an early benefit assessment that “an additional benefit could not be documented” for Xultophy insulin degludec/liragluti...